Contribution: Industrial Research Assistance Program – Contributions to Firms
Pharmasilico Technologies Inc.
$45,820.00
Artificial intelligence-based compound screening system for drug discovery
EF 2019-20 · 2019-09-01
Résumé
The inaccuracy of the available computational methods limits the success rate of structure-based in silico drug screening. By taking advantage of abundant experimental data and state-of-the-art artificial intelligence technologies, we are developing a system which overcomes the weaknesses of current screening methods.
Ministère
Programme
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (lien de confiance élevée)
Bénéficiaire
Emplacement
Vancouver|Vancouver, British Columbia, Canada
Type de bénéficiaire
For-profit organization
Numéro d'entreprise
766039887
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Tel que publié
Agreement End Date
2020-03-31
Agreement Number
933368
Agreement Start Date
2019-09-01
Agreement Title
Artificial intelligence-based compound screening system for drug discovery
Agreement Title (French)
Système de dépistage de composés basé sur l'intelligence artificielle pour la découverte de médicaments
Agreement Type
Contribution
Agreement Value
$45,820.00
Amendment Number
0
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
The inaccuracy of the available computational methods limits the success rate of structure-based in silico drug screening. By taking advantage of abundant experimental data and state-of-the-art artificial intelligence technologies, we are developing a system which overcomes the weaknesses of current screening methods.
Description (French)
L'inexactitude des méthodes de calcul disponibles limite le taux de réussite du dépistage des drogues en silice basé sur la structure. En tirant parti de données expérimentales abondantes et de technologies d'intelligence artificielle de pointe, nous développons un système qui corrige les faiblesses des méthodes actuelles de dépistage.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Vancouver Quadra
Federal Riding (French)
Vancouver Quadra
Federal Riding Number
59039
NAICS Code
541710
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
766039887
Recipient City
Vancouver|Vancouver
Recipient Country
CA
Recipient Legal Name
Pharmasilico Technologies Inc.
Recipient Postal Code
V6T 1W5
Recipient Province or Territory
BC
Recipient Type
F
Reference Number
172-2019-2020-Q2-933368
